Vanda Pharmaceuticals Inc.
The record holds no confirmed move for Vanda Pharmaceuticals Inc.
Moves
The record holds no appointment or departure for Vanda Pharmaceuticals Inc. in its window. It appears here because of the pay rows below, from its proxy statement.
Pay rows
- Joakim Wijkstrom, Senior Vice President, Chief Marketing Officer, fiscal 2025: total $1,457,528 as filed in the DEF 14A of 23 April 2026.
About this page
A company page gathers what the record holds: moves checked against the company's own announcements, SEC filings or established publications, and pay rows copied from its proxy statements (8 columns of the Summary Compensation Table where the filing has them). The sentence at the top is written in code from the newest confirmed move; when that move is more than 18 months old it says who held the seat then, never who holds it now. Reported moves never change it.
The record's current edition covers announcements from 25 June 2026 to 23 October 2026; a company with no move in that window can still have one outside it.
See the full record and its method, or the corrections page if something here is wrong.